期刊文献+

氨基末端B型利钠肽前体与高血压患者主动脉顺应性的相关性 被引量:5

下载PDF
导出
摘要 目的探讨氨基末端B型利钠肽前体(amino-terminal pro-fragment proBNP,NT-proBNP)与高血压患者主动脉顺应性的相关性。方法入选原发性高血压患者106例,利用超声心动图检测评价患者主动脉张力、膨胀性及僵硬指数,同时测定血浆NT-proBNP水平。分析NT-proBNP水平与主动脉顺应性指标之间是否存在相关性。结果 Pearson积矩相关系数分析NT-proBNP与年龄(r=0.41,P<0.05)、主动脉僵硬指数(r=0.44,P<0.05)呈正相关,与主动脉张力(r=-0.45,P<0.05)、膨胀性指数(r=-0.32,P<0.05)呈负相关。校正年龄因素影响后计算偏相关系数,NT-proBNP与主动脉僵硬指数(r=0.32,P<0.01)呈正相关,与主动脉张力(r=-0.28,P<0.05)、膨胀性指数(r=-0.21,P<0.05)呈负相关。结论高血压患者动脉顺应性降低与NT-proBNP存在一定程度相关,NT-proBNP是高血压患者动脉顺应性降低的一个早期预测因子。
出处 《广东医学》 CAS CSCD 北大核心 2010年第20期2695-2697,共3页 Guangdong Medical Journal
基金 广东省佛山市卫生局医学科研立项项目(编号:2010385)
  • 相关文献

参考文献9

  • 1FROHLICH E D.Target organ involvement in hypertension:a realistic promise of prevention and reversal[J].Med Clin North Am,2004,88(1):209-221.
  • 2ARNETT D K,EVANS G,RILEY W A.Arterial stiffness:a new cardiovascular risk factor[J].Am J Epidemiol,1994,140(8):669-682.
  • 3BOUTOUYRIE P,LAURENT S,BRIET M.Importance of arterial stiffness as cardiovascular risk factor for future development of new type of drugs[J].Fundam Clin Pharmacol,2008,22(3):241-246.
  • 4MARTINEZ RUMAYOR A,RICHARDS A M,BURNETT J C,et al.Biology of the natriuretic peptides[J].Am J Cardiol,2008,101(3A):3-8.
  • 5黄裕立,吴焱贤.N末端脑钠肽原在心血管疾病诊治及预后中的应用进展[J].国际内科学杂志,2009,36(2):74-77. 被引量:24
  • 6DIEPLINGER B,POELZ W,HALTMAYER M,et al.Association of adiponectin and amino terminal proBNP in peripheral arterial disease[J].Clin Chim Acta,2007,377(1-2):192-197.
  • 7CELIK T,IYISOY A,ACIKEL C,et al.The comparative effects of metoprolol and perindopril on aortic elasticity in young patients with prehypertension[J].Blood Press Monit,2008,13(3):169-176.
  • 8CHOBANIAN A V,BAKRIS G L,BLACK H R,et al.Seventh report of the Joint National Committee on Prevention,Detection,Evaluation,and Treatment of High Blood Pressure[J].Hypertension,2003,42(6):1206-1252.
  • 9OLSEN M H,WACHTELL K,NIELSEN O W,et al.N-terminal brain natriuretic peptide predicted cardiovascular events stronger than high-sensitivity C-reactive protein in hypertension:a LIFE substudy[J].J Hypertens,2006,24(8):1531-1539.

二级参考文献25

  • 1Bayes-Genis A, Santalo-Bel M, Zapico-Muniz E, et al. Nterminal probrain natriuretic peptide (NT-proBNP) in the emergency diagnosis and in-hospital monitoring of patients with dyspnoea and ventricular dysfunction. Eur J Heart Fail, 2004,6(3) :301-308.
  • 2Di Somma S, Magrini L, Mazzone M, et al. Decrease in NTproBNP plasma levels indicates clinical improvement of acute decompensated heart failure. Am J Emerg Med, 2007, 25(3) :335-339.
  • 3Bettencourt P, Januzzi JL Jr. Amino-terminal pro.B-type natriuretic peptide testing for inpatient monitoring and treatment guidance of acute destabilized heart failure. Am J Cardiol, 2008, 101(3A) :67-71.
  • 4Lainchbury JG, Troughton RW, Frampton CM, et al. NT- proBNP-gnided drug treatment for chronic heart failure:design and methods in the “ BATYLESCARRED” trial. Eur J Heart Fail, 2006,8(5) :532-538.
  • 5Brunner-La Rocca HP, Buser PT, Schindler R, et al. Management of elderly patients with congestive heart failure-design of the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIMECHF). Am Heart J, 2006,151(5) :949-955.
  • 6Troughton RW, Riehards AM. Outpatient monitoring and treatment of chronic heart failure guided by amino-terminal pro-B-type natriuretic peptide measurement. Am J Cardiol, 2008,101 (3A) :72-75.
  • 7Martinez-Rumayor A, Richards AM, Burnett JC, et al. Biology of the natriuretic peptides. Am J Cardiol, 2008,101 (3A) :3-8.
  • 8Azzazy HM, Christenson RH, Duh SH. Stability of B-type natriuretic peptide(BNP) in whole blood and plasma stored under different conditions when measured with the Biosite Triage or Beckman-Coulter Access systems. Clin Chim Acta. 2007. 384(1-2):176-178.
  • 9Galasko GI, Lahiri A, Barnes SC, et al. What is the normal range for N-terminal pro-brain natriuretic peptide? How well does this normal range screen for cardiovascular disease? . Eur Heart J, 2005,26(21 ) :2269-2276.
  • 10Anwaruddin S, Lloyd-Jones DM, Baggish A, et at. Renal function, congestive heart failure, and amino-terminal probrain natriuretic peptide measurement:results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study. J Am Coil Cardiol, 2006, 47(1) :91-97.

共引文献23

同被引文献29

引证文献5

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部